Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
108.1 USD | -1.59% |
|
-5.63% | -12.13% |
20/06 | Needham Adjusts Price Target on Jazz Pharmaceuticals to $210 From $222, Maintains Buy Rating | MT |
20/06 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.13% | 6.93B | |
+55.19% | 801B | |
+47.26% | 631B | |
-6.09% | 359B | |
+21.92% | 337B | |
+18.40% | 245B | |
+3.64% | 231B | |
+12.98% | 219B | |
+10.86% | 171B | |
-2.78% | 161B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Transcript : Jazz Pharmaceuticals plc Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 02